Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline?

Journal of Clinical Psychiatry

Volumn 57, Issue 2, 1996, Pages 67-71

  Zarate Jr , Carlos A ^a,b   Kando, Judith C ^a   Tohen, Mauricio ^a,b,c   Weiss, Michelle K ^a   Cole, Jonathan O ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PSYCHOTROPIC AGENT; SERTRALINE;

ARTICLE; BIPOLAR DEPRESSION; DEPRESSION; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; OBSESSION; PREDICTION; PRIORITY JOURNAL; RASH; SCHIZOIDISM; TREMOR; VERTIGO;

1-NAPHTHYLAMINE; ADOLESCENT; ADULT; BIPOLAR DISORDER; DEPRESSIVE DISORDER; DRUG TOLERANCE; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TREATMENT OUTCOME;

EID: 0030044651     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Baldessarini RJ. Current status of antidepressants: clinical pharmacology and therapy. J Clin Psychiatry 1989;50:117-126
2. Koe KB, Weissmann A, Welch WM, et al. Sertraline: a new selective inhibitor of serotonin uptake. Psychopharmacol Bull 1983;19:687-691
3. Rickels K, Schweizer E. Clinical overview of serotonin reuptake inhibitors. J Clin Psychiatry 1990;51(12, suppl B):9-12
4. Heym J, Koe BK. Pharmacology of sertraline: a review. J Clin Psychiatry 1988;49(8, suppl):40-45
5. Chouinard G, Goodman W, Griest J, et al. Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacol Bull 1990;26: 279-284
6. Koe KB. Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake. J Clin Psychiatry 1990;51(12, suppl B):13-17
7. Guthrie SK. Sertraline: a new specific serotonin reuptake blocker. Ann Pharmacother 1991;25:952-961
8. Doogan DP, Caillard V. Sertraline: a new antidepressant. J Clin Psychiatry 1988;49(8, suppl):46-51
9. Brown W, Harrison W. Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another? J Clin Psychiatry 1995; 56:30-34
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987
11. Guy W, ed. ECDEU Assessment Manual for Psychopharmacology, Revised. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976
12. Banov MD, Zarate CA Jr, Tohen M, et al. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry 1994;55:295-300
13. Statistical Analysis System. Cary, NC: SAS Institute; 1989
14. Sackett DL. Bias in analytic research. J Chronic Disorders 1979;32:51-57
15. Sackett DL, Gent M. Controversy in counting and attributing events in clinical trials. N Engl J Med 1979;301:1410-1412
16. Reimherr FW, Byerley WF, Ward MJ, et al. Setraline, a selective inhibitor of serotonin uptake, for the treatment of outpatients with major depressive disorder. Psychopharmacol Bull 1988;24:200-205
17. Reimherr FW, Chouinard G, Cohn CK, et al. Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry 1990;51(12, suppl B):18-27
18. Butler J, Leonard BE. The platelet serotonergic system in depression and following sertraline treatment. Int Clin Psychopharmacol 1988;3:343-347
19. Leznoff A, Binkley KE, Joffee RT, et al. Adverse cutaneous reactions associated with fluoxetine strategy for reintroduction of this drug in selected patients. J Clin Psychopharmacol 1992;12:355-357
20. Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990;147:207-210
21. Quitkin FM, Stewart JW, McGrath PJ, et al. Further evidence that a placebo response to antidepressants can be identified. Am J Psychiatry 1993; 150:566-570
22. Nierenberg AA, Amsterdam JD. Treatment-resistant depression: definition and treatment approaches. J Clin Psychiatry 1990;51(6, suppl):39-47
23. Tohen M. Bias and other methodological issues in follow-up (cohort) research studies. In: Fava M, Rosenbaum JF, eds. Research Designs and Methods in Psychiatry. Amsterdam, The Netherlands: Elsevier; 1992: 119-125